Latest profit margin for BerGenBio ASA: -1118.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for BRRGF is -1118.85% as of June 2026. That compares with -45159.78% in the prior-year period — up 97.5% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside BerGenBio ASA's historical trend and sector peers before judging valuation or financial health.
Over the past year, BRRGF's profit margin moved from -45159.78% to -1118.85% — a 97.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BerGenBio ASA's valuation or profitability profile.
Against Healthcare companies, BRRGF currently prints -1118.85% for profit margin, while the sector average sits near 17.63%. That is roughly 6446.8% below the sector mean. Large gaps often invite a closer look at BerGenBio ASA's growth, margins, and balance sheet.
Profit Margin shows how effectively BerGenBio ASA converts resources into returns. At -1118.85%, BRRGF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -45159.78% in the prior-year period — up 97.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BRRGF's profit margin (-1118.85%), review year-over-year change from -45159.78%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.